My understanding of WDDD and WORX.
Most of my understanding is from the companies own SEC reports. WDDD shows zero revenue for Q1 2014, but I am willing to overlook that because of the patent case that is going on and the value I expect from it eventually. I own shares in WDDD on the basis of what I expect is the present value of the patents and the October 2014 Markman hearing.
WORX shows $222 in Q1 2014 revenue. While it does have a license to use the online patents from WDDD, with WDDD approval, it looks like they are not able to do anything meaningful with them.
I have no objections to WORX being sold off as a shell for some other company looking for a low cost way to get access to public markets, but I think the hype surrounding the new joint venture/probably future reverse merger is not warranted since the LLC does not seem to have any operations. I would prefer a company that has ongoing operations (and is profitable) to be doing a reverse merger into WORX. That I would feel good about.
While I am a libertarian on drug policy, I do not feel good about, in effect, being a part owner in a company that will be pushing such use, plus I do not see enough demand for such a product/service to justify the valuations that people are looking at (or fear will come if WORX starts to get pumped).
Louis J. Desy Jr
LouisDesyjr@gmail.com